Aquaporin-Targeted Therapeutics: State-of-the-Field.
Aquaporin-Targeted Therapeutics: State-of-the-Field.
复制标题
DOI:
10.1007/978-94-024-1057-0_16
复制
发表时间:
2017
影响因子:
--
通讯作者:
Verkman AS
中科院分区:
文献类型:
--
作者:
Tradtrantip L;Jin BJ;Yao X;Anderson MO;Verkman AS
Drugs targeting aquaporins have broad potential clinical applications, including cancer, obesity, edema, glaucoma, skin diseases and others. The astrocyte water channel aquaporin-4 is a particularly compelling target because of its role of brain water movement, neuroexcitation and glia scarring, and because it is the target of pathogenic autoantibodies in the neuroinflammatory demyelinating disease neuromyelitis optica. There has been considerable interest in the identification of small molecule inhibitors of aquaporins, with various candidates emerging from testing of known ion transport inhibitors, as well as compound screening and computational chemistry. However, in general, the activity of reported aquaporin inhibitors has not been confirmed on retesting, which may be due to technical problems in water transport assays used in the original identification studies, and the challenges in modulating the activity of small, compact, pore-containing membrane proteins. We review here the state of the field of aquaporin-modulating small molecules and biologics, and the challenges and opportunities in moving forward.
登录
查看更多内容
DOI:
10.1085/jgp.201110712
发表时间:
2012-01
期刊:
The Journal of general physiology
影响因子:
--
作者:
Baumgart F;Rossi A;Verkman AS
通讯作者:
Verkman AS
影响因子:
82.9
作者:
Manley, GT;Fujimura, M;Verkman, AS
通讯作者:
Verkman, AS
影响因子:
3.4
作者:
Martins, Ana Paula;Ciancetta, Antonella;Casini, Angela
通讯作者:
Casini, Angela
DOI:
10.1073/pnas.1210662109
发表时间:
2012-11-20
影响因子:
11.1
作者:
Baum, Bruce J.;Alevizos, Ilias;Illei, Gabor G.
通讯作者:
Illei, Gabor G.
影响因子:
3.5
作者:
Huber, Vincent J.;Tsujita, Mika;Nakada, Tsutomu
通讯作者:
Nakada, Tsutomu